Haleon updates total voting rights and share capital

Haleon plc reported its updated share capital and voting rights position.

Accepted by SEC EDGAR 06/01/2026 - 06:53 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Haleon plc reported its updated share capital and voting rights position. As at 31 May 2026, the company had 8,859,337,794 ordinary shares of £0.01 each in issue, of which 12,076,964 were held as treasury shares.

This leaves 8,847,260,830 ordinary shares with voting rights. Haleon explains that this voting-rights figure should be used by shareholders and other obliged investors as the denominator when calculating whether they must notify holdings or changes in holdings under the FCA’s Disclosure Guidance and Transparency Rules.

Key Figures

Total shares issued: 8,859,337,794 ordinary shares Treasury shares: 12,076,964 ordinary shares Shares with voting rights: 8,847,260,830 ordinary shares +2 more

5 metrics

Total shares issued 8,859,337,794 ordinary shares As at 31 May 2026

Treasury shares 12,076,964 ordinary shares Held in treasury as at 31 May 2026

Shares with voting rights 8,847,260,830 ordinary shares Voting-rights denominator as at 31 May 2026

Ordinary share nominal value £0.01 each Nominal value per ordinary share

Exhibit reference Exhibit 99.1 Total Voting Rights and Capital notice dated 01 June 2026

Key Terms

treasury shares, Total Voting Rights and Capital, Disclosure Guidance and Transparency Rules, ordinary shares, +1 more

5 terms

treasury shares financial

"of which 12,076,964 are held as treasury shares."

Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.

Total Voting Rights and Capital financial

"Haleon plc: Total Voting Rights and Capital 01 June 2026:"

Disclosure Guidance and Transparency Rules regulatory

"under the FCA's Disclosure Guidance and Transparency Rules."

Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.

ordinary shares financial

"8,859,337,794 ordinary shares of £0.01 each"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

denominator financial

"used by shareholders ... as the denominator for the calculation"

The denominator is the number on the bottom of a fraction that shows the total population or base used to calculate a rate, percentage or ratio — for example, the total shares outstanding when calculating earnings per share, or all trial participants when reporting a safety rate. It matters to investors because changing the denominator (by issuing more shares, changing the population measured, or narrowing the base) can make percentages and per‑unit figures look better or worse even if the underlying raw numbers stay the same, much like changing the size of a pizza makes each slice appear larger or smaller.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Haleon (HLN) reporting in this June 2026 6-K?

Haleon is reporting its total share capital and voting rights as at 31 May 2026. The update helps investors calculate whether they must disclose holdings under FCA transparency rules using the latest voting-rights denominator.

How many Haleon (HLN) shares are currently in issue?

Haleon states that 8,859,337,794 ordinary shares of £0.01 each were in issue as at 31 May 2026. This figure includes both shares in public hands and those held in treasury by the company itself.

How many Haleon (HLN) shares carry voting rights?

Haleon reports that 8,847,260,830 ordinary shares carry voting rights as at 31 May 2026. This is the total issued shares minus the 12,076,964 ordinary shares held in treasury, which do not confer voting rights.

How many Haleon (HLN) shares are held in treasury?

Haleon holds 12,076,964 ordinary shares as treasury shares as at 31 May 2026. Treasury shares are issued but not entitled to vote, so they are excluded from the voting-rights total used for disclosure calculations.

How should Haleon (HLN) investors use the voting-rights figure?

Investors should use 8,847,260,830 as the denominator when assessing if they must notify Haleon shareholdings. This figure underpins disclosures of interests or changes in interests required under the FCA’s Disclosure Guidance and Transparency Rules.

Where can notifiable interests in Haleon (HLN) be sent?

Notifiable interests in Haleon may be sent to the email address company.secretary@haleon.com. The filing identifies this contact for shareholders and others who must report positions under applicable UK disclosure and transparency regulations.

What type of business is Haleon (HLN)?

Haleon is a consumer company focused on better everyday health, with brands such as Advil, Centrum, Panadol, Sensodyne and Voltaren. Its portfolio spans oral health, vitamins and supplements, pain relief, respiratory, digestive and therapeutic skin health categories.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	01 June 2026 - Total Voting Rights and Capital

99.1

Haleon plc: Total Voting Rights and Capital

01 June 2026: As at 31 May 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,859,337,794 ordinary shares of £0.01 each, of which 12,076,964 are held as treasury shares.

Therefore, the number of ordinary shares with voting rights is 8,847,260,830 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notifiable interests in Haleon may be sent to: company.secretary@haleon.com

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: June 01, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary